Finance

Lists
Why is OBAT down 2,44%?
Dive Deeper
OBAT:IDX
Brigit Biofarmaka Teknologi Tbk PT
240,00 IDR
-2,44%
(-6,00) 1D
20 қар., 16:00:03 GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for OBAT...
Open
240 IDR
High
246 IDR
Low
240 IDR
Mkt. cap
163,29 млрд
Avg. vol.
409,71 м.
Volume
120,20 м.
Dividend
3,14%
Quarterly dividend
2 IDR
Ex-dividend date
2026 ж. 22 мам.
P/E ratio
8,44
52-wk high
434 IDR
52-wk low
190 IDR
EPS
28 IDR
Shares outstanding
680,38 млн
No. of employees
240
Open
240 IDR
High
246 IDR
Low
240 IDR
Mkt. cap
163,29 млрд
Avg. vol.
409,71 м.
Volume
120,20 м.
Dividend
3,14%
Quarterly dividend
2 IDR
Ex-dividend date
2026 ж. 22 мам.
P/E ratio
8,44
52-wk high
434 IDR
52-wk low
190 IDR
EPS
28 IDR
Shares outstanding
680,38 млн
No. of employees
240
News stories
From web sources and news partners
Adam Feldman | Substack
Adam Feldman | Substack
·
18 сағат бұрын
Inside the Federal Litigation of Five S&P 500 Giants
RealMoney Pro
RealMoney Pro
·
14 сағат бұрын
Anthropic Pops, but the S&P 500 Drops
The Harvard Law School Forum on Corporate Governance
The Harvard Law School Forum on Corporate Governance
·
1 күн бұрын
Board Practices and Composition in the Russell 3000 and S&P 500
About Brigit Biofarmaka Teknologi Tbk PT
CEO-
Employees240
Founded2015
Headquarters-
SectorConsumer Staples
IndustryPersonal care products
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
38,18 млрд
45,37 млрд
43,82 млрд
45,18 млрд
Cost of goods sold
18,76 млрд
35,71 млрд
28,17 млрд
28,27 млрд
Cost of revenue
18,76 млрд
35,71 млрд
28,17 млрд
28,27 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,92 млрд
6,42 млрд
10,53 млрд
10,81 млрд
Operating expense
8,67 млрд
7,08 млрд
10,83 млрд
10,70 млрд
Total operating expenses
27,43 млрд
42,80 млрд
39,00 млрд
38,97 млрд
Operating income
10,75 млрд
2,57 млрд
4,83 млрд
6,21 млрд
Other non operating income
-54,54 млн
165,04 млн
242,73 млн
-92,66 млн
EBT including unusual items
10,67 млрд
3,27 млрд
4,87 млрд
5,83 млрд
EBT excluding unusual items
10,69 млрд
3,25 млрд
4,87 млрд
5,83 млрд
Income tax expense
4,46 млрд
2,80 млрд
-
1,39 млрд
Effective tax rate
41,86%
85,71%
-
23,88%
Other operating expenses
751,69 млн
660,16 млн
296,55 млн
-105,38 млн
Net income
2,38 млрд
2,47 млрд
2,92 млрд
4,40 млрд
Net profit margin
6,22%
5,44%
6,65%
9,75%
Earnings per share
-
-
-
-
Interest and investment income
149,39 млн
1,36 млрд
72,42 млн
13,58 млн
Interest expense
-156,33 млн
-1,34 млрд
-266,58 млн
-301,05 млн
Net interest expenses
-6,94 млн
19,56 млн
-194,16 млн
-287,47 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
11,71 млрд
2,63 млрд
5,73 млрд
7,38 млрд
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google қолданбалары